Researchers at the Johns Hopkins Kimmel Cancer Center report that an artificial intelligence (AI)-based liquid biopsy test ...

Ipilimumab-nivolumab also linked with better survival but more toxicity in small study ...

Fatty liver disease, encompassing metabolic-associated fatty liver disease (MAFLD) and alcohol-associated liver disease (ALD), is now a significant global health issue. MAFLD is closely linked to ...

Mayo Clinic researchers have identified a rare mutation in the MET gene that can directly cause metabolic dysfunction-associated steatotic liver disease. The mutation disrupts the liver’s ability to ...

The FDA expanded the indication for semaglutide (Wegovy) to treating adults with noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH), the agency announced. The glucagon-like peptide-1 ...

Metabolic dysfunction-associated steatotic liver disease (MASLD) can cause more serious liver conditions, such as liver failure. A new study, led by Lund University in Sweden, presents new data that ...

The sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin, widely used to treat type 2 diabetes, also shows improvements for patients with progressive liver disease, finds a clinical ...

Semaglutide, the active ingredient in the weight loss drugs Wegovy and Ozempic, may offer benefits far beyond weight management. New research suggests the drug could help treat a serious liver ...

Your face serves as a remarkable window into your overall health, often revealing internal problems long before you experience obvious symptoms. When it comes to fatty liver disease, one of the most ...